Cytokinetics | CYTK - Loan Capital



Cytokinetics reported $713.04M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Amgen USD 53.76B 253M Jun/2025
Bayer EUR 31.71B 3.31B Jun/2025
Biogen USD 6.28B 1.74B Jun/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Cytokinetics USD 713.04M 67.88M Jun/2025
Eisai JPY 99.84B 9M Jun/2025
Eli Lilly USD 34.18B 319.4M Jun/2025
Exelixis USD 0 0 Apr/2025
Geron USD 118.99M 263K Jun/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
Ligand Pharmaceuticals USD 0 0 Mar/2025
Merck USD 33.97B 484M Jun/2025
Novartis USD 24.06B 2.4B Jun/2025
Pfizer USD 57.5B 137M Jun/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
Sanofi 13.2B 211M Jun/2025